Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
Not yet recruiting · NCT06887452 · Registry updated 2026-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout | Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Not yet recruiting | Not applicable | 2026-02-19 | NCT06887452 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VA Office of Research and Development | 472 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA | Philadelphia | United States | 25 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Omaha | United States | 14 |
| VA Portland Health Care System, Portland, OR | Portland | United States | 30 |
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle | United States | 32 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Salt Lake City | United States | 24 |